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rum calcitriol values is best attributed to feeding-induced de-Effects of fasting, feeding, and bisphosphonate administration
creases in serum phosphate. APD administration indepen-on serum calcitriol levels in phosphate-deprived rats.
dently increases serum calcitriol levels in rats on normal andBackground. In a recent study, we showed in phosphate-
phosphate-deprived diets. Finally, whether our results in thedeprived rats that morning feeding decreased serum phosphate
rat are applicable to the clinical setting should be evaluatedand increased serum calcium values as compared with similar
rats fasted overnight, and high doses of bisphosphonates did because in previous human studies of dietary phosphate restric-
not reduce the magnitude of hypercalcemia. In the present tion, serum calcitriol measurements were performed the morn-
study, we evaluated in phosphate-deprived rats whether serum ing after an overnight fast.
calcitriol values were: (1) affected by the differences in serum
phosphate induced by morning feeding and overnight fasting,
(2) correlated with changes in serum phosphate levels, and (3)
Previous studies have shown that dietary phosphateinfluenced by bisphosphonate administration.
Methods. Four groups of rats were studied: (1) low-phos- deprivation in animals and dietary phosphate restriction
phate diet (LPD; P , 0.05%), (2) LPD 1 the bisphosphonate in humans stimulate calcitriol production [1–6]. It has
pamidronate (APD), (3) normal diet (ND; P 0.6%), and (4) also been shown that both hypophysectomy and diabetes
ND 1 APD. Both diets contained 0.6% calcium. In rats receiv-
reduce the stimulation of calcitriol by phosphate depriva-ing APD, high doses (0.8 mg/kg) were given subcutaneously
tion [7–10], and treatment with either insulin, growth hor-four times during the study. On day 11, rats were sacrificed after
an overnight fast or two to four hours after morning feeding. mone, or insulin-like growth factor-I (IGF-I) restores the
Results. In the fed phosphate-deprived rats (LPD and LPD 1 capacity of phosphate deprivation to stimulate calcitriol
APD), serum phosphate levels were less (P , 0.05) and serum [8, 10–12]. In the aforementioned studies, the effect thatcalcium levels were greater (P , 0.05) than in similar rats
several days of phosphate deprivation had on calcitriolfasted overnight. In rats on the ND (ND and ND 1 APD),
stimulation was evaluated, but the effect that feeding andno differences were observed between fed and fasted rats. In
phosphate-deprived rats, serum calcitriol levels were greater fasting had on serum calcium, phosphate, and calcitriol
(LPD, P , 0.05) or tended to be greater (LPD 1 APD, P 5 levels was not specifically addressed. In previous studies
0.10) in the fed than in the fasted groups. In APD-treated rats,
in phosphate-deprived rats, feeding after an overnightserum calcitriol values were greater than in rats not given APD
fast has been shown to induce rapidly marked hypophos-whether rats were (1) fed or fasted, or (2) on an LPD or ND.
An inverse correlation was present between serum phosphate phatemia and hypercalcemia [13–15]. In studies of phos-
and serum calcitriol (r 5 20.58, P 5 0.001). In a stepwise phate restriction in young healthy men, often there has
regression model in which serum calcitriol was the dependent not been any difference in serum phosphate values ob-variable and independent variables were APD administration
tained after an overnight fast between subjects on normaland serum calcium, phosphate, and PTH, serum phosphate (P 5
diets and those on phosphate-restricted diets [16–19]. In0.003) had an inverse and APD (P , 0.001) administration a
direct effect on serum calcitriol (r2 5 0.59). studies in young healthy women, a small difference in
Conclusion. Calcitriol synthesis is rapidly inducible in rats serum phosphate was present after an overnight fast
during chronic phosphate deprivation, and the increase in se-
between volunteers on a normal diet and those on a
phosphate-restricted diet [16, 17]. Finally, it has been
1 Present address: Department of Nephrology, Hospital Clinico, San- shown that the small difference present in fasting serum
tiago, Chile. phosphate values becomes much greater after breakfast
because of the postfeeding decrease in serum phosphateKey words: hypercalcemia, parathyroid hormone, dietary phosphate,
metabolism. values in those on the phosphate-restricted diet [20].
In previous studies, the capacity of dietary phosphateReceived for publication December 27, 1999
deprivation to increase serum calcitriol values has beenand in revised form March 16, 2000
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fasting and feeding was not specifically studied. BecauseÓ 2000 by the International Society of Nephrology
1016
Felsenfeld et al: Phosphate deprivation, feeding, bisphosphonates, and calcitriol 1017
Fig. 1. Schematic diagram of the study de-
sign. Shown are the four groups of rats, the
diets used in the study, the days on which
Pamidronate (APD) was administered, and
the day of sacrifice.
feeding rapidly changes serum phosphate and calcium tories, Shenandoah, IA, USA). Rats were housed in indi-
vidual cages, given 14 g of food daily between 8 and 9values in the phosphate-deprived rat, it would seem rea-
sonable to evaluate the effect that feeding has on the a.m., and were allowed free access to water.
The two diets used during the study were providedsimultaneous values of serum calcitriol and phosphate in
such rats. In a recent publication, we showed that two by the same supplier (ICN, Cleveland, OH, USA) and
contained 0.6% calcium and 100 IU of vitamin D perto four hours of feeding in rats with prolonged dietary
phosphate deprivation rapidly decreased serum phosphate 100 g of diet. Dietary phosphate content was either
,0.05% (low phosphate diet; LPD) or 0.6% (normaland increased serum calcium values [15]. We also showed
that these postfeeding changes were not prevented with diet; ND). As shown in Figure 1, two groups received
bisphosphonate treatment and that bisphosphonate treat- the LPD, and two groups received the ND. In one LPD
ment increased serum calcitriol values. In the present and one ND group, the bisphosphonate, Pamidronate
report, we show that (1) in phosphate-deprived rats, (APD), was administered subcutaneously two days be-
feeding rapidly increases serum calcitriol levels and the fore the start of the study diet and on days 2, 6, and 9
decrease in serum phosphate induced by feeding corre- during the 11 days of the study diet. The dose of APD
lates with the magnitude of increase in serum calcitriol used (0.8 mg/kg) is a high dose [21, 22], which, as we
levels, and (2) bisphosphonate administration indepen- recently showed, results in a marked alteration of osteo-
dently increases serum calcitriol values in rats whether clast morphology and a reduction in the osteoblast sur-
maintained on a normal or low-phosphate diet. face [15]. Thus, the four groups of rats studied were (1)
LPD, (2) LPD 1 APD, (3) ND, and (4) ND 1 APD.
Blood was obtained on day 11 after an overnight fastMETHODS
(approximately 12 to 14 hours without food) or two to
In a recent publication [15], we evaluated in phos- four hours after early morning feeding.
phate-deprived rats the effect of bisphosphonate (Pami- Serum calcium and phosphate were measured with
dronate, Novartis, Summit, NJ, USA) administration on specific kits (Sigma, St. Louis, MO, USA), serum creati-
the development of hypercalcemia and the calcemic re- nine with a creatinine analyzer (Beckman, Fullerton,
sponse to parathyroid hormone (PTH). In that study, CA, USA), serum PTH with an immunoradiometric
approximately one half of the rats were sacrificed on day assay specific for intact rat PTH (Nichols, San Juan Cap-
11 of the study diet, and in the other rats, an Alzet pump istrano, CA, USA), and serum calcitriol with a radiore-
containing 1-34 rat PTH was implanted for two days ceptor assay by Nichols Institute.
to evaluate the calcemic response to PTH. In the rats
sacrificed on day 11, blood was obtained by aortic punc- Statistics
ture, and in the other half, blood was obtained on day Comparisons of the data among the eight groups were
11 from the tail vein before implantation of the Alzet assessed by one-way analysis of variance (ANOVA) fol-
pump. Only in the rats in which blood was obtained from lowed by a post hoc test, the Fisher LSD, for multiple
the aorta was the blood volume sufficient to measure comparisons. For the correlation between two variables,
calcitriol. Even in a few of these latter rats, the amount of the Pearson’s correlation was used. For these tests, a
serum available was found to be insufficient to measure P value , 0.05 was considered significant. A stepwise
calcitriol by the independent laboratory (Nichols Insti- regression was used to determine the effect of indepen-
tute, San Juan Capistrano, CA, USA) to which the sam- dent variables on a dependent variable. Results are
ples were sent. shown as the mean 6 SE.
Male Wistar rats weighing 160 to 180 g were used for
the study. During procedures, rats were anesthetized
RESULTSwith intraperitoneally administered ketamine 7.5 mg/100 g
(Ketaset; Fort Dodge Laboratories, Fort Dodge, IA, There were no differences among the eight groups in
serum creatinine values (ANOVA, P 5 0.49), the weightUSA) and xylazine 0.5 mg/100 g (AnaSed; Lloyd Labora-
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Table 1. Serum calcium, phosphate, parathyroid hormone (PTH), and calcitriol values in rats sacrificed by aortic puncture on Day 11
Calciuma Phosphatea PTHa Calcitriola
Serum mg/dL pg/mL
Fasted
LPD (N 5 4) 10.5860.28 9.3660.89 1666 235642
LPD 1 APD (N 5 4) 11.3660.78 7.1260.96 1568 366629e
ND (N 5 4) 9.5360.02 8.7060.61 85614 19868
ND 1 APD (N 5 4)b 9.5260.17 8.7660.87 92625 303618
Fed
LPD (N 5 4) 12.4260.45c 5.0060.58c 661 347658c
LPD 1 APD (N 5 3) 12.9360.37c 4.6360.64c 761 460649d,e
ND (N 5 4) 9.6060.24 8.6760.12 61617 198613
ND 1 APD (N 5 4)b 10.0360.18 9.8060.91 7467 387651f
ANOVA ,0.001 ,0.001 ,0.001 ,0.001
Data are mean 6 SE.
aComparisons not shown between groups on normal diet and groups on low phosphate diet
bFor calcitriol, the N 5 2
cP , 0.05 vs. same group, fed vs. fasted
dP 5 0.10 vs. same group, fed vs. fasted
eP , 0.05 vs. LPD in fed and fasted grouping
fP , 0.05 vs. ND in fed grouping
at sacrifice (ANOVA, P 5 0.29), and the weight gained
during the study (ANOVA, P 5 0.13). Table 1 shows
the serum calcium, phosphate, PTH, and calcitriol values
in fasted and fed rats. The values for serum calcium,
phosphate, and PTH are similar to those in our recent
publication that included additional rats in which blood
was obtained from the tail vein [15]. As shown in Table
1, serum calcium values were greater (P , 0.05) and
serum phosphate values were less (P , 0.05) in fed
than in fasted phosphate-deprived rats (LPD and LPD 1
APD). In rats on the ND (ND and ND 1 APD), there
was no difference in serum calcium and phosphate values
between the fed and fasted groups. PTH values were
less in the groups on the LPD (LPD and LPD 1 APD)
than in the groups on the ND (ND and ND 1 APD),
but there were no differences in PTH values between
fed and fasted rats in the same dietary group. Serum
calcitriol values were greater (P , 0.05) in the fed than
in the fasted phosphate-deprived group (LPD) and also
tended to be greater (P 5 0.10) in the fed than in the
fasted LPD 1 APD group. The administration of APD
increased serum calcitriol levels in rats both on a phos-
phate-deprived and ND, independent of whether rats
were fed or fasted.
Fig. 2. Correlation between serum calcitriol and serum phosphate inAs shown in Figure 2, when a comparison between
rats on a normal diet (ND) or a low protein diet (LPD). The correlationserum phosphate and calcitriol was performed, an in- between serum calcitriol and phosphate is shown for all rats sacrificed
verse correlation was present (r 5 20.58, P 5 0.001). on day 11 (r 5 20.58; P 5 0.001). Symbols are: (j) LPD-fasted; ( )
LPD-fed; (.) LPD 1 APD-fasted; (,) LPD 1 APD-fed; (d) ND-Separating the rats into fed and fasted groups (Fig. 3)
fasted; (s) ND-fed; (m) ND 1 APD-fasted; (n) ND 1 APD-fed.improved the correlation (r 5 20.67, P 5 0.01) between
serum phosphate and calcitriol in fed rats (Fig. 3A), but
reduced the correlation (r 5 20.30, P 5 NS) in fasted rats
(Fig. 3B). Moreover, APD treatment tended to increase effect of independent variables (phosphate, calcium,
serum calcitriol levels across a wide range of serum phos- PTH, and bisphosphonate treatment) on the dependent
phate values (Fig. 3C). variable, serum calcitriol (Table 2). While serum phos-
phate, calcium, and PTH were continuous variables, bis-Stepwise regression was performed to determine the
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Fig. 3. Correlation between serum calcitriol and serum phosphate and the effect of (A) feeding, (B) fasting, and (C) APD treatment. Symbols
in A (fed) and B (fasted) are: (j) LPD; (.) LPD 1 APD; (d) ND; (m) ND 1 APD. Symbols in C are: (d) no APD; (s) APD. In the latter
group, the correlation between serum calcitriol and phosphate in rats treated with APD was r 5 20.54, P 5 0.08, and in rats not treated with
APD, the correlation was r 5 20.60, P 5 0.01.
phosphonate treatment was either absent or present. As
shown in Table 2, when all rats (N 5 27) were included,
the r2 value was 0.59; serum phosphate had a strong
inverse effect, and bisphosphonate administration had a
strong positive effect on serum calcitriol values. TheTable 2. Stepwise regression for rats in which serum calcitriol values
effects of calcium and PTH were not significant. Whenwere available
only fed rats (N 5 13) were evaluated, the r2 value wast value P value
0.85. Again, serum phosphate had a strong inverse effect,
All rats and bisphosphonate administration had a strong positiveDependent variable
effect on serum calcitriol values (Table 2). Serum calciumSerum calcitriol
Independent Variables also had a minor effect. In fasted rats (N 5 14), the r2
Serum phosphate 23.4 0.003 value was 0.63. Bisphosphonate administration contin-Bisphosphonate administration 3.8 ,0.001
ued to have a strong positive effect, and PTH had aSerum calcium 0.8 NS
PTH 0.8 NS minor effect; however, serum phosphate no longer had





Serum phosphate 24.1 0.003 In rats maintained for 10 days on the LPD, morning
Bisphosphonate administration 4.7 0.002 feeding after an overnight fast induced a rapid decreaseSerum calcium 21.9 0.10
in serum phosphate values and a rapid increase in serumPTH 0.7 NS
r 2 50.85 calcium values. Associated with the rapid decrease in
Fasted rats serum phosphate values was a similarly rapid increaseDependent variable
in serum calcitriol values. In rats maintained on the ND,Serum calcitriol
Independent variables morning feeding did not change serum phosphate, cal-
Serum phosphate 0.9 NS cium, and calcitriol values. Finally, in rats maintainedBisphosphonate administration 3.9 0.002
on either the ND or LPD and in both the fed and fastedSerum calcium 0.7 NS
PTH 21.2 0.27 states, bisphosphonate administration independently in-
r 2 50.63 creased serum calcitriol values.
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In previous studies in rats maintained on phosphate- Our determination of the effect of feeding and fasting
on serum calcium, phosphate, PTH, and calcitriol levelsdeprived or restricted diets, feeding has been shown to
produce a rapid decrease in serum phosphate values was performed in rats that had been on the LPD for 10
days. Other studies in the rat have shown that a similar[13, 14]. As a result of elegant studies performed in rats
on phosphate-restricted (0.2% P) diets, it was suggested LPD for even shorter durations results in decreases in
serum phosphate values. It has been shown that by 24that (1) fasting increased serum phosphate values be-
cause it resulted in an efflux of phosphate into the extra- hours of the LPD, serum phosphate values decrease
[4, 31] and serum calcitriol levels increase [4]. Otherscellular space [14], and (2) calcitriol treatment together
with an increase in serum calcium in thyroparathyroidec- have shown that serum phosphate values decrease by
four to six hours after the start of the LPD [32, 33].tomized rats enhanced the net exit of phosphate from
the extracellular space into soft tissue or bone [23]. While Perhaps even more interesting is that Levine et al have
shown that in rats previously maintained on the ND,the rats in the present study were not parathyroidecto-
mized, PTH values in the rats on the LPD were very low. gavage with the LPD resulted in a decrease in serum
phosphate values by one hour [34]. It is not knownThus, in our phosphate-deprived rats, it is possible that
the feeding-induced increases in serum calcium and whether these rapid changes in serum phosphate are
associated with increases in serum calcitriol.calcitriol levels were important in facilitating the shift of
phosphate into cells. In previous studies in rats and humans on phosphate-
deprived or restricted diets, hypophysectomy or growthIn previous studies in animals and humans, the increase
in serum calcitriol values during phosphate deprivation hormone deficiency has been shown to blunt or prevent
the stimulation of calcitriol [7, 9, 10, 35]. Other studieshas been shown to be due to an increase in calcitriol
production [3, 24–26] and not to a decrease in the meta- have suggested that IGF-I is an important mediator of
calcitriol stimulation during phosphate restriction [9–12,bolic clearance rate [25, 26]. The rapid increase in serum
calcitriol values that we observed within four hours after 36, 37]. However, previous studies have reported that
IGF-I levels do not increase rapidly after feeding or otherthe start of feeding was somewhat surprising. Moreover,
the strong inverse correlation that was observed between stimuli [38, 39]. Finally, insulin has also been suggested to
be an important mediator of the calcitriol response toserum calcitriol and the degree of hypophosphatemia,
and the significance of the serum phosphate concentra- phosphate deprivation [8, 10]. In the present study, the
effect of feeding on changes in phosphate and calcitrioltion in the stepwise regression suggests that the feeding-
induced decrease in serum phosphate was an important stimulation was rapid, and the role—if any—of growth
hormone, insulin, or even IGF-I remains to be determined.factor in the rapid increase of serum calcitriol levels.
The results of the present study also pose some poten- The present study also shows that bisphosphonate ad-
ministration independently increases serum calcitriol val-tially important questions. In essentially all previous clin-
ical studies of dietary phosphate restriction, blood for ues. Studies from the 1970s showed that the first-generation
bisphosphonate, etidronate, inhibited 1-a-hydroxylasecalcitriol was drawn in the morning after an overnight
fast [16–20, 25, 27]. Thus, it is possible that the true activity [40, 41]. In subsequent studies in which third-
generation bisphosphonates, which contain a basic pri-magnitude of calcitriol stimulation was not observed.
Because the degree of dietary phosphate restriction is mary nitrogen atom on the R2 alkyl side chain, were used
for the treatment of hypercalcemia of malignancy [42],much less in clinical studies than in studies in rats, it
could be argued that feeding might not induce the same Paget’s disease [42–44], and juvenile osteoporosis [45]
or were given to normal volunteers [46], an elevation ofdegree of hypophosphatemia and calcitriol stimulation.
However, in the study in rats by Trohler, Bonjour, and serum calcitriol levels was observed. In these studies,
the elevation in serum calcitriol levels was attributed toFleisch, the effect of fasting and feeding on serum phos-
phate was observed with only a moderately phosphate- concomitant increases in PTH levels. However, several
studies have reported that the administration of third-restricted diet (0.2% P) [14]. Moreover, in the clinical
studies of Portale, Halloran, and Morris, normal men on generation bisphosphonates to parathyroidectomized rats
[47, 48] or to cyclosporine-treated rats in which PTH levelsa phosphate-restricted diet had a much greater decrease
in serum phosphate after breakfast than when ingesting did not change [49] resulted in increases in serum calcitriol
values. In one of these studies, it was also reported thata normal or high-phosphate diet [19, 20]. As far as we
can determine, little information is available on feeding- the in vitro addition of bisphosphonates increased 1-a-
hydroxylase activity in mitochondria obtained from kid-induced changes in serum calcitriol values in such situa-
tions. While studies in normal humans during normal neys removed from bisphosphonate-treated rats [48]. In
our study, bisphosphonate administration had an effectdietary calcium and phosphate ingestion have shown di-
urnal variations in serum calcitriol levels to be small on calcitriol stimulation that by stepwise regression was
shown to be essentially equal to that of phosphate depri-[28–30], the effect of dietary phosphate restriction was
not evaluated in these studies. vation. The effect of bisphosphonate administration was
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1,25(OH)2D by phosphorus in the rat. Calcif Tissue Int 33:477–484,observed both in rats on NDs and LPDs. Furthermore,
1981
the increase in serum calcitriol levels was even observed 6. Kimmel PL, Watkins DW, Slatopolsky E, Langman CB:
1,25(OH)2D response to combined zinc and phosphorus depletionin phosphate-deprived rats with very low PTH levels.
in rats. Am J Physiol 22:E319–E326, 1990The present study contained only a relatively small
7. Gray RW: Control of plasma 1,25(OH)2-vitamin D concentrationsnumber of rats in each group because, besides our inten- by calcium and phosphorus in the rat: Effect of hypophysectomy.
Calcif Tissue Int 33:485–488, 1981tion to evaluate the effect of bisphosphonates on serum
8. Matsumoto T, Kawanobe Y, Ezawa I, Shibuya N, Hata K, Ogatacalcium and phosphate levels in phosphate-deprived rats,
E: Role of insulin in the increase in serum 1,25-dihydroxyvitamin
the original study was designed to evaluate the calcemic D concentrations in response to phosphorus deprivation in strepto-
zotocin-induced diabetic rats. Endocrinology 118:1440–1444, 1986response to a PTH infusion [15]. Since the measurement
9. Harbison MD, Gertner JM: Permissive action of growth hormoneof serum calcitriol levels was not part of the original on the renal response to dietary phosphorus deprivation. J Clin
design, serum calcitriol values could not be measured in Endocrinol Metab 70:1035–1040, 1990
10. Grieff M, Zhong M, Finch J, Ritter CS, Slatopolsky E, Brownrats in which blood samples were obtained from the tail
AJ: Renal calcitriol synthesis and serum phosphorus in responsevein. However, the findings that significant differences to dietary phosphorus restriction and anabolic agents. Am J Kidney
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15. Jara A, Lee E, Stauber D, Felsenfeld AJ, Kleeman CR: Phos-phosphate level. (3) In rats on an ND, feeding had no phate depletion in the rat: The effect of bisphosphonates and the
effect on serum calcitriol and phosphate values. (4) High- calcemic response to PTH. Kidney Int 55:1434–1443, 1999
16. Dominguez JH, Gray RW, Lemann J Jr: Dietary phosphate depri-dose bisphosphonate administration independently in-
vation in women and men: Effects on mineral and acid balances,creased serum calcitriol values in rats on LPDs and NDs; parathyroid hormone and the metabolism of 25-OH-vitamin D.
this effect was observed in both the fed and fasted states. J Clin Endocrinol Metab 43:1056–1068, 1976
17. Gray RW, Wilz DR, Caldas AE, Lemann J Jr: The importanceIn conclusion, calcitriol synthesis appears to be rapidly
of phosphate in regulating plasma 1,25(OH)2 vitamin D levels ininducible in rats during chronic phosphate deprivation, humans: Studies in healthy subjects, in calcium-stone formers and
in patients with primary hyperparathyroidism. J Clin Endocrinoland the increase in serum calcitriol values is best attrib-
Metab 45:299–306, 1977uted to feeding-induced decreases in serum phosphate.
18. Maierhofer WJ, Gray RW, Lemann J Jr: Phosphate deprivation
Finally, whether our results of feeding-induced calcitriol increases serum 1,25-(OH)2-vitamin D concentrations in healthy
men. Kidney Int 25:571–575, 1984stimulation in phosphate-deprived rats are applicable
19. Portale AA, Halloran BP, Morris RC Jr: Physiologic regulationto the clinical setting should be evaluated, because in
of the serum concentration of 1,25-dihydroxyvitamin D by phos-
previous human studies of dietary phosphate restriction, phorus in man. J Clin Invest 83:1494–1499, 1989
20. Portale AA, Halloran BP, Morris RC Jr: Dietary intake ofmeasurements of serum calcitriol were performed the
phosphorus modulates the circadian rhythm in serum concentra-morning after an overnight fast.
tion of phosphorus. J Clin Invest 80:1147–1154, 1987
21. Muhlbauer RC, Bauss F, Schenk R, Janner M, Bosies E, StreinReprint requests to Arnold J. Felsenfeld, M.D., Nephrology Section
K, Fleisch H: Bm 21.095, a potent new bisphosphonate to inhibit(111L), West Los Angeles VA Medical Center, 11301 Wilshire Boule-
bone resorption. J Bone Miner Res 6:1003–1011, 1991vard, Los Angeles, California 90073, USA.
22. Azuma Y, Sato H, Oue Y, Kabe K, Ohta T, Tsuchimoto M, KiyokiE-mail: afelsenf@ucla.edu
M: Alendronate distributed on bone surfaces inhibits osteoclastic
bone resorption in vitro and in experimental hypercalcemia mod-
els. Bone 16:235–245, 1995REFERENCES
23. Troehler U, Bonjour J-P, Fleisch H: Extrarenal handling of
1. Tanaka Y, DeLuca HF: The control of 25-hydroxyvitamin D phosphate: Effect of thyroparathyroidectomy, 1,25-dihydroxycho-
metabolism by inorganic phosphorus. Arch Biochem Biophys lecalciferol, and dietary calcium. Am J Physiol 249:F912–F918,
154:566–574, 1973 1985
2. Hughes MR, Brumbaugh PF, Haussler MR, Wergedal JE, Bay- 24. Gray RW, Napoli JL: Dietary phosphorus deprivation increases
link DJ: Regulation of serum 1a,25-dihydroxyvitamin D3 by cal- 1,25 dihydroxyvitamin D3 synthesis in rat kidney in vitro. J Biol
cium and phosphate in the rat. Science 190:578–580, 1975 Chem 258:1152–1155, 1983
3. Baxter LA, DeLuca HF: Stimulation of 25-hydroxyvitamin D3-1 25. Portale AA, Halloran BP, Murphy MM, Morris RC Jr: Oral
alpha-hydroxylase by phosphate depletion. J Biol Chem 251:3158– intake of phosphorus can determine the serum concentration of
3161, 1976 1,25-dihydroxyvitamin D by determining its production rate in
4. Rader JI, Baylink DJ, Hughes MR, Safilian EF, Haussler MR: humans. J Clin Invest 77:7–12, 1986
Calcium and phosphorus deficiency in rats: Effects on PTH and 26. Fox J, Ross R: Effects of low phosphorus and low calcium diets
1,25-dihydroxyvitamin D3. Am J Physiol 236:E118–E122, 1979 on the production and metabolic clearance rates of 1,25-dihydroxy-
cholecalciferol in pigs. J Endocrinol 105:169–173, 19855. Gray RW: Effects of age and sex on the regulation of plasma
Felsenfeld et al: Phosphate deprivation, feeding, bisphosphonates, and calcitriol1022
27. Insogna KL, Broadus AE, Gertner JM: Impaired phosphorus acidosis on the growth hormone/IGF-1 endocrine axis: New cause
of growth hormone insensitivity in humans. Kidney Int 51:216–221,conservation and 1,25 dihydroxyvitamin D generation during phos-
phorus deprivation in familial hypophosphatemic rickets. J Clin 1997
40. Hill LF, Lumb GA, Mawer EB, Stanbury SW: Indirect inhibitionInvest 71:1562–1569, 1983
28. Adams ND, Gray RW, Lemann J Jr: The effects of oral CaCO3 of the biosynthesis of 1,25-dihydroxycholecalciferol in rats treated
with a diphosphonate. Clin Sci 44:335–347, 1973loading and dietary calcium deprivation on plasma 1,25-dihydrox-
yvitamin D concentrations in healthy adults. J Clin Endocrinol 41. Baxter LA, DeLuca HF, Bonjour JP, Fleisch HA: Inhibition
of vitamin D metabolism by ethane-1-hydroxy-1,1-diphosphonate.Metab 48:1008–1016, 1979
29. Prince RL, Wark JD, Omond S, Opie JM, Eagle MR, Eisman Arch Biochem Biophys 164:655–662, 1974
42. Papapoulos SE, Harinck HIJ, Bijvoet OLM, Gleed JH, FraherJA: A test of 1,25-dihydroxyvitamin D3 secretory capacity in normal
subjects for application in metabolic bone diseases. Clin Endocrinol LJ, O’Riordan JLH: Effects of decreasing serum calcium on circu-
lating parathyroid hormone and vitamin D metabolites in normo-(Oxf) 18:127–133, 1983
30. Halloran BP, Portale AA, Castro M, Morris RC Jr, Goldsmith calcaemic and hypercalcaemic patients treated with APD. Bone
Miner 1:69–78, 1986RS: Serum concentration of 1,25 dihydroxyvitamin D in the human:
Diurnal variation. J Clin Endocrinol Metab 60:1104–1110, 1985 43. Adami S, Frijlink WB, Bijvoet OLM, O’Riordan JLH, Clemens
TL, Papapoulos SE: Regulation of calcium absorption by 1,25,31. Kreusser WJ, Kurokawa K, Eznar E, Sachtjen E, Massry SG:
Effect of phosphate depletion on magnesium homeostasis. J Clin dihydroxy-vitamin D: Studies of the effects of a bisphosphonate
treatment. Calcif Tissue Int 34:317–320, 1982Invest 61:573–581, 1978
32. Ivey JL, Morey ER, Baylink DJ: The effects of phosphate deple- 44. Devlin RD, Retallack RW, Fenton AJ, Grill V, Gutteridge
DH, Kent GN, Prince RL, Worth GK: Long-term elevation oftion on bone. Adv Exp Med Biol 103:373–380, 1978
33. Levine BS, Ho K, Hodsman A, Kurokawa K, Coburn JW: Early 1,25-dihydroxyvitamin D after short-term intravenous administra-
tion of pamidronate (aminohydroxypropylidene bisphosphonate,renal brush border membrane adaptation to dietary phosphorus.
Miner Electrolyte Metab 10:222–227, 1984 APD) in Paget’s disease of bone. J Bone Miner Res 9:81–85, 1994
45. Brumsen C, Hamdy NAT, Papapoulos SE: Long-term effects of34. Levine BS, Ho LD, Pasiecznik K, Coburn JW: Renal adaptation
to phosphorus deprivation: Characterization of early events. J Bone bisphosphonates on the growing skeleton. Medicine (Baltimore)
76:266–283, 1997Miner Res 1:33–40, 1986
35. Gray RW, Garthwaite TL: Activation of renal 1,25-dihydroxyvi- 46. Netelenbos JC, Van Ginkel FC, Lips P, Leeuwenkamp OR,
Barto R, Van Der Vijgh WJF, Van Der Wiel H, Hackeng WHL:tamin D3 synthesis by phosphate deprivation: Evidence for a role
for growth hormone. Endocrinology 116:189–193, 1985 Effect of a single infusion of aminohydroxypropylidene on calcium
and bone metabolism in healthy volunteers monitored during 236. Condamine L, Vztovsnik F, Friedlander G, Menaa C, Garabe-
dian M: Local action of phosphate depletion and insulin-like months. J Clin Endocrinol Metab 72:223–228, 1991
47. Bonjour J-P, Treschel U, Taylor CM, Fleisch H: Parathyroidgrowth factor 1 on in vitro production of 1,25-dihydroxyvitamin
D by cultured mammalian kidney cells. J Clin Invest 94:1673–1679, hormone-independent regulation of 1,25(OH)2D in response to
inhibition of bone resorption. Am J Physiol 254:E260–E264, 19881994
37. Wong M-S, Sriussadaporn S, Tembe V, Favus MJ: Insulin-like 48. Nagao Y, Ishitobi Y, Kinoshita H, Fukushima S, Kawashima H:
YM175, a new bisphosphonate, increases serum 1,25-dihydroxyvi-growth factor I increases renal 1,25(OH)2D3 biosynthesis during
low-P diet in adult rats. Am J Physiol 272:F698–F703, 1997 tamin D in rats via stimulating renal 1-hydroxylase activity. Bio-
chem Biophys Res Commun 180:1172–1178, 199138. Giordano M, Castellino P, McConnell EL, Defronzo RA:
Effect of amino acid infusion on renal hemodynamics in humans: 49. Sass DA, Bowman AR, Yuan Z, Ma Y, Jee WSS, Epstein S:
Alendronate prevents cyclosporin A-induced osteopenia in theA dose response study. Am J Physiol 267:F703–F708, 1994
39. Brungger M, Hulter HN, Krapf R: Effect of chronic metabolic rat. Bone 21:65–70, 1997
